Opportunity

CanadaBuys #PS27RFPFORLENALIDOMIDEANDPOMALIDOMIDE

Solicitation for Oncology Lenalidomide and Pomalidomide Oral Solids

Posted

June 09, 2026

Respond By

July 14, 2026

Identifier

PS27RFPFORLENALIDOMIDEANDPOMALIDOMIDE

NAICS

424210

This opportunity is a national solicitation for Oncology Lenalidomide and Pomalidomide Oral Solids for Canadian healthcare institutions. - Government Buyer: - HealthPRO Procurement Services Inc. (on behalf of Nova Scotia Health and IWK) - Products/Services Requested: - Lenalidomide oral solid medications - Pomalidomide oral solid medications - No specific part numbers or quantities provided - OEMs and Vendors: - No OEMs or vendors are named in the notice - Notable Requirements: - Part of the PS27 contract cycle - Open to competitive proposals under the Canadian Free Trade Agreement (CFTA) and the Canada-European Union Comprehensive Economic and Trade Agreement (CETA) - Contract documents and amendments are accessed via the Euna platform - Estimated contract duration is 36 months

Description

HealthPRO Procurement Services Inc. is soliciting proposals for a contract involving Oncology Lenalidomide and Pomalidomide Oral Solids. The contract duration is estimated to be 36 months. The procurement method is competitive open bidding under Canadian trade agreements including CFTA and CETA. Access to contract documents is available through the Nova Scotia Procurement Portal, and the contracting authority is Shivani Sounthararasa.

View original listing